4.6 Article

Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS

Journal

ACTA NEUROPATHOLOGICA COMMUNICATIONS
Volume 7, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s40478-019-0673-y

Keywords

FUS; Heterogeneous nuclear ribonucleoprotein; hnRNP R; hnRNP Q; FTLD; Frontotemporal lobar degeneration

Categories

Funding

  1. Alzheimer's Research UK
  2. Leonard Wolfson Centre for Experimental Neurology
  3. European Research Council (ERC) under the European Union [648716 - C9ND]
  4. Motor Neurone Disease Association
  5. UK Dementia Research Institute
  6. Reta Lila Weston Institute for Neurological Studies
  7. Medical Research Council
  8. MRC [UKDRI-1006] Funding Source: UKRI

Ask authors/readers for more resources

Frontotemporal lobar degeneration (FTLD) is pathologically subdivided based on the presence of particular pathological proteins that are identified in inclusion bodies observed post-mortem. The FTLD-FUS subgroup is defined by the presence of the fused in sarcoma protein (FUS) in pathological inclusions. FUS is a heterogeneous nuclear ribonucleoprotein (hnRNP) protein and a member of the FET (FUS, EWS, TAF15) protein family. It shuttles between the nucleus and cytoplasm, and has been implicated in many cellular functions including translation, splicing, and RNA transport. EWS, TAF15 and the nuclear import receptor transportin have been shown to co-accumulate with FUS in neuronal inclusions specifically in FTLD-FUS, with transportin-positive inclusions most frequently observed. Here, we report the identification of hnRNP R and hnRNP Q in neuronal cytoplasmic and intranuclear inclusions in the frontal cortex and hippocampus of FTLD-FUS patients, as frequently as transportin. hnRNP R and hnRNP Q were not found in the characteristic pathological inclusions observed in FTLD-TDP (subtypes A-C). Additionally, we studied the expression of hnRNP R in the frontal and temporal cortices from patients with FTLD and found significantly increased expression of the heterogeneous nuclear ribonucleoprotein R in several FTLD disease groups. Our identification of the frequent presence of hnRNP R and hnRNP Q in FTLD-FUS inclusions suggests a potential role for these hnRNPs in FTLD-FUS pathogenesis and supports the role of dysfunctional RNA metabolism in FTLD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia

D. Hansen, H. Ling, T. Lashley, J. A. Foley, C. Strand, T. M. Eid, J. L. Holton, T. T. Warner

Summary: This study identified prominent concurrent cerebral amyloid angiopathy (CAA) as a pathological substrate of DLB and found that DLB has more severe CAA and faster disease progression compared to PDD. The absence of dyskinesia in DLB is linked to lower lifetime cumulative dose of levodopa than PDD.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2021)

Article Clinical Neurology

HnRNP K mislocalisation in neurons of the dentate nucleus is a novel neuropathological feature of neurodegenerative disease and ageing

Rahul Sidhu, Ariana Gatt, Pietro Fratta, Tammaryn Lashley, Alexander Bampton

Summary: This study reveals that nuclear depletion and cytoplasmic mislocalisation of hnRNP K are common neuropathological features in FTLD and elderly control brain. Furthermore, the dentate nucleus of the cerebellum is also vulnerable to hnRNP K mislocalisation. The findings suggest that hnRNP K dysfunction may have broader relevance to neurodegeneration and ageing.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2022)

Article Clinical Neurology

The severity of behavioural symptoms in FTD is linked to the loss of GABRQ-expressing VENs and pyramidal neurons

Priya Gami-Patel, Marta Scarioni, Femke H. Bouwman, Baayla D. C. Boon, John C. van Swieten, Netherlands Brain Bank, Annemieke J. M. Rozemuller, August B. Smit, Yolande A. L. Pijnenburg, Jeroen J. M. Hoozemans, Anke A. Dijkstra

Summary: This study investigates the vulnerability of von Economo neurons (VENs) and GABA receptor subunit theta (GABRQ)-expressing neurons in different forms of frontotemporal dementia (FTD) and their association with behavioral symptoms. The results suggest that the loss of VENs and GABRQ-expressing neurons is linked to TDP43 and FUS pathology in FTD, and may play a key role in modulating behavior.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2022)

Meeting Abstract Biochemistry & Molecular Biology

The Extracellular Chaperone Clusterin in Aβ and Non-Aβ Cerebral Amyloidoses

Agueda Rostagno, Miguel Calero, Janice Holton, Tamas Revesz, Tammaryn Lashley, Jorge Ghiso

FASEB JOURNAL (2022)

Meeting Abstract Biochemistry & Molecular Biology

Enhanced Brain Retention of Aβ4-x Proteoforms and its Contribution to Amyloid Deposits in Alzheimer's Disease

Jorge Ghiso, Erwin Cabrera, Tammaryn Lashley, Agueda Rostagno

FASEB JOURNAL (2022)

Editorial Material Neurosciences

Imaging tau pathology in Alzheimer's disease with positron emission tomography: lessons learned from imaging-neuropathology validation studies

Alexis Moscoso, Melissa C. Wren, Tammaryn Lashley, Erik Arstad, Melissa E. Murray, Nick C. Fox, Kerstin Sander, Michael Scholl

MOLECULAR NEURODEGENERATION (2022)

Article Multidisciplinary Sciences

Age-dependent formation of TMEM106B amyloid filaments in human brains

Manuel Schweighauser, Diana Arseni, Melissa Huang, Sofia Lovestam, Yang Shi, Yang Yang, Wenjuan Zhang, Abhay Kotecha, Holly J. Garringer, Ruben Vidal, Grace Hallinan, Kathy L. Newell, Airi Tarutani, Shigeo Murayama, Masayuki Miyazaki, Yuko Saito, Mari Yoshida, Kazuko Hasegawa, Tammaryn Lashley, Tamas Revesz, Gabor G. Kovacs, John van Swieten, Masaki Takao, Masato Hasegawa, Bernardino Ghetti, Benjamin Falcon, Alexey G. Murzin, Michel Goedert, Sjors H. W. Scheres, Maria Grazia Spillantini

Summary: The study found that TMEM106B protein forms amyloid filaments in the brains of patients with various neurodegenerative diseases. The structures of TMEM106B filaments differ in different brain regions and do not show clear associations with specific diseases. The presence of TMEM106B filaments in the brains of older individuals suggests an age-dependent formation pattern, which is not observed in younger individuals with normal neurology.

NATURE (2022)

Article Biochemistry & Molecular Biology

Chemical traits of cerebral amyloid angiopathy in familial British-, Danish-, and non-Alzheimer 's dementias

Wojciech Michno, Srinivas Koutarapu, Rafael Camacho, Christina Toomey, Katie Stringer, Karolina Minta, Junyue Ge, Durga Jha, Julia Fernandez-Rodriguez, Gunnar Brinkmalm, Henrik Zetterberg, Kaj Blennow, Natalie S. Ryan, Tammaryn Lashley, Jorg Hanrieder

Summary: Familial British dementia (FBD) and familial Danish dementia (FDD) are autosomal dominant forms of dementia caused by mutations in the ITM2B gene. The amyloid pathology in FBD/FDD manifests in the microvasculature, with FDD also showing co-aggregation with A beta. Using mass spectrometry imaging and fluorescence probes, researchers found differences in amyloid peptide species between FBD and FDD, providing new insights into the pathogenesis of vascular dementias.

JOURNAL OF NEUROCHEMISTRY (2022)

Article Clinical Neurology

Epigenetic age acceleration is associated with oligodendrocyte proportions in MSA and control brain tissue

Megha Murthy, Gemma Shireby, Yasuo Miki, Emmanuelle Vire, Tammaryn Lashley, Thomas T. Warner, Jonathan Mill, Conceicao Bettencourt

Summary: This study investigated the epigenetic aging in white matter for the first time, and found that oligodendrocyte proportions positively influence epigenetic age acceleration.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2023)

Article Neurosciences

Moderate intrinsic phenotypic alterations in C9orf72 ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features

Ileana Lorenzini, Eric Alsop, Jennifer Levy, Lauren M. Gittings, Deepti Lall, Benjamin E. Rabichow, Stephen Moore, Ryan Pevey, Lynette M. Bustos, Camelia Burciu, Divya Bhatia, Mo Singer, Justin Saul, Amanda McQuade, Makis Tzioras, Thomas A. Mota, Amber Logemann, Jamie Rose, Sandra Almeida, Fen-Biao Gao, Michael Marks, Christopher J. Donnelly, Elizabeth Hutchins, Shu-Ting Hung, Justin Ichida, Robert Bowser, Tara Spires-Jones, Mathew Blurton-Jones, Tania F. Gendron, Robert H. Baloh, Kendall Van Keuren-Jensen, Rita Sattler

Summary: In this study, researchers investigate the role of non-neuronal cells, specifically microglia, in C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD). They find that iPSC-derived microglia from C9orf72 ALS/FTD patients exhibit pathological features and perform similar functions as healthy control microglia. Transcriptomic analysis reveals selective transcriptional changes related to neuroinflammation and neurodegeneration in diseased microglia. The findings suggest that a diseased microenvironment is required to induce phenotypic changes in microglia and the associated neuronal dysfunction in C9orf72 ALS/FTD.

FRONTIERS IN CELLULAR NEUROSCIENCE (2023)

Review Cell Biology

HnRNP Pathologies in Frontotemporal Lobar Degeneration

Xinwa Jiang, Ariana Gatt, Tammaryn Lashley

Summary: Frontotemporal dementia (FTD) is the second most common form of early-onset dementia, characterized by behavioral, executive, and/or language impairment. Frontotemporal lobar degeneration (FTLD) is the main cause of FTD and is associated with the abnormal accumulation of proteins like tau, TAR DNA-binding protein 43 (TDP-43), and fused in sarcoma (FUS). Recent studies have expanded the exploration of the relationship between other heterogeneous ribonucleic acid proteins (hnRNPs) and FTLD pathology, revealing the association between hnRNP abnormalities and FTLD. These findings highlight the important role of multiple hnRNPs in the development of FTLD and suggest the need for further research on this protein family.

CELLS (2023)

Article Clinical Neurology

Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum

Lauren M. Gittings, Eric B. Alsop, Jerry Antone, Mo Singer, Timothy G. Whitsett, Rita Sattler, Kendall Van Keuren-Jensen

Summary: Recent study found that the loss of TDP-43 function leads to the inclusion of cryptic exons (CE) in RNA transcript targets, and these CE-containing transcripts were detected in the sensory and visual cortices of C9ORF72-related ALS and FTD patients. In C9ORF72-FTD patients, a cluster of excitatory neurons containing CEs showed transcriptomic similarities to von Economo neurons. Dysregulated metabolic processes were found in CE-containing neurons through gene expression and pathway analysis. These findings provide novel insights into the transcriptomic changes in neurons vulnerable to TDP-43 pathology.

ACTA NEUROPATHOLOGICA (2023)

Article Cell Biology

Epigenetic Age Acceleration in Frontotemporal Lobar Degeneration: A Comprehensive Analysis in the Blood and Brain

Megha Murthy, Patrizia Rizzu, Peter Heutink, Jonathan Mill, Tammaryn Lashley, Conceicao Bettencourt

Summary: Frontotemporal lobar degeneration (FTLD) is a group of disorders characterized by degeneration of the frontal and temporal lobes. Recent research has shown that significant differential DNA methylation in DLX1 and OTUD4 loci may contribute to FTLD. This study found that there is accelerated epigenetic aging in FTLD patients compared to controls, particularly in peripheral blood. The findings suggest that increased epigenetic age acceleration in peripheral blood could be an indicator for FTLD subtypes like progressive supranuclear palsy (PSP) and frontotemporal dementia (FTD).

CELLS (2023)

Meeting Abstract Clinical Neurology

HnRNP K mislocalisation in Frontotemporal Lobar Degeneration leads to cryptic exon inclusion

Ariana Gatt, Alex Bampton, Jack Humphrey, Sara Cappelli, Emanuele Buratti, Pietro Fratta, Tammaryn Lashley

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2021)

Article Clinical Neurology

A Clinicopathologic Study of Movement Disorders in Frontotemporal Lobar Degeneration

Eduardo de Pablo-Fernandez, Belen Gonzalez-Herrero, Debora Cerdan Santacruz, Martin N. Rossor, Jonathan M. Schott, Tammaryn Lashley, Janice L. Holton, Nick C. Fox, Tamas Revesz, Jason D. Warren, Zane Jaunmuktane, Jonathan D. Rohrer, Thomas T. Warner

Summary: This study provides a detailed description of movement disorders in FTLD patients, finding that parkinsonism and corticobasal syndrome are common syndromes associated with FTLD, with parkinsonism presenting more often in the late stages of the disease and corticobasal syndrome as an initial symptom. The study also suggests that there is a complex pathophysiology involving structures beyond the presynaptic striatonigral system in FTLD-related movement disorders.

MOVEMENT DISORDERS (2021)

No Data Available